Export 21 results:Author Title [ Type] Year
Filters: First Letter Of Title is E [Clear All Filters]
Effect of HIV-1 subtype on virological and immunological response to first-line HAART. 6th European HIV Drug Resistance Workshop, 26-28 March 2008.. 2008.
Effect of HIV-1 subtype on virological and immunological response to first-line HAART. British HIV Association 14th Annual Conference, 23-25 April 2008.. 2008.
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.. 2010.
The emergence of drug resistant HIV variants at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine within the UK CHIC cohort. 18th Annual Conference of the British HIV Association, 18-20 April 2012.. 2012.
Epidemiology of non-B clade forms of HIV-1 in MSM in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.. 2007.
Estimating resistance in drug experienced patients in the UK. 13th International Drug Resistance Workshop, 8-12 June 2004.. 2004.
Estimating the heritability of viral determination of progression rate. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.. 2012.
Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis. 48:1296-305.. 2009.
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.. AIDS. 32(3):327-335.. 2018.
Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance. BMC Med Res Methodol. 12:30.. 2012.
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 11:363-71.. 2011.
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. AIDS. 24:1917-22.. 2010.
The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort. J Infect. 68:77-84.. 2014.
Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy. J Antimicrob Chemother. 59:1013-6.. 2007.
Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK. AIDS. 24:2397-401.. 2010.
Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis. 192:967-73.. 2005.
Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.. BMC Med Res Methodol. 18(1):65.. 2018.
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men. HIV Med. 13:309-14.. 2012.
Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. Clin Infect Dis. 61:829-36.. 2015.